Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan.
about
Inhibition of mutation and combating the evolution of antibiotic resistanceSerratia infections: from military experiments to current practice.Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis.Resistance pattern of ciprofloxacin against different pathogens.Bacteriology of Naja atra Snakebite Wound and Its Implications for Antibiotic Therapy.Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusionsChanges in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens.Bacteremia in patients with hematological malignancies.Antimicrobial susceptibility of Flavobacterium psychrophilum isolates from Ontario.Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.Formulation development and stability studies of norfloxacin extended-release matrix tablets.Activity of twelve second-line antimicrobial agents against Mycobacterium tuberculosis in Taiwan.Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines.Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates.Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: an eight-year single center experience.Serratia infections in a general hospital: characteristics and outcomes.Obesity was an independent risk factor for febrile infection after prostate biopsy: A 10-year single center study in South China.
P2860
Q21146100-B56C7325-EBE6-4B02-B5C0-66A306ADE720Q30424691-A146D474-F68B-4F8C-8204-33E7C6508798Q34011984-81B85130-CEDA-4898-977A-B72DCA757F52Q35323705-764DE44E-8271-4331-A499-25B05CA7734DQ36869579-6266E678-6C9C-480F-BFDD-CE623B6B5B11Q37697210-B2D872E0-A8D2-4859-86FA-6E7A09BD8726Q40496949-407A7CDD-CDB7-46C7-B7DB-DAA639E6BB1FQ40508848-076C708C-7B37-4DA5-9064-08F9E5BAFE87Q43006773-9C267A9B-5D0D-4D63-8D7B-6ED69F94B6C4Q44990860-8D5B40D2-B564-4D1F-B3F5-3E08E3EE903AQ45032510-E3336A9B-F7D8-4924-B983-C2BDA79C6C20Q46604521-5EEED988-11BC-434E-8878-C3446BB0C5B3Q46614086-61AE95F3-EAF7-4006-ACD2-43BEA5F62F73Q46832047-682AF4A1-E6B0-4C77-824F-5E238170DFD9Q46855613-F01F2562-C991-4BE1-BC55-62E88D62E5A6Q51237342-7CB49126-8A92-499A-8A2A-99DCBB5D072AQ51733596-08A4643E-89E2-4178-BF3A-D4A9A26FBD20Q52673993-A817A075-1951-4BA3-A4E0-8721D693ABD8
P2860
Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@en
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@nl
type
label
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@en
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@nl
prefLabel
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@en
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@nl
P50
P1476
Emerging fluoroquinolone-resis ...... m-negative bacteria in Taiwan.
@en
P2093
Kwen-Tay Luh
Wei-Chuan Hsieh
P304
P356
10.1016/S0732-8893(02)00381-4
P577
2002-06-01T00:00:00Z